Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:May 21, 2020Withdrawn
Hide Studies Not Open or Pending
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:May 21, 2020Withdrawn
Condition(s):Intrahepatic Cholangiocarcinoma RecurrentLast Updated:August 21, 2020Not yet recruiting
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:April 1, 2016Unknown status
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:July 9, 2014Unknown status
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:May 12, 2020Recruiting
Condition(s):Intrahepatic Cholangiocarcinoma by AJCC V8 StageLast Updated:June 4, 2020Recruiting
Condition(s):Unresectable Intrahepatic Cholangiocarcinoma; Resectable Intrahepatic CholangiocarcinomaLast Updated:April 13, 2016Terminated
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:September 29, 2020Recruiting
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:August 8, 2019Recruiting
Condition(s):Bile Duct Neoplasms; Colorectal NeoplasmsLast Updated:May 6, 2020Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.